Scholar Rock
Scholar Rock's Overview
Scholar Rock is a biopharmaceutical company dedicated to discovering and developing a new class of medicines that selectively target protein growth factors in the disease microenvironment. Their focus is on creating transformative therapies for patients with serious conditions, including neuromuscular disorders, cancer, and fibrosis. By modulating the activation of these growth factors, Scholar Rock aims to address the underlying causes of these diseases and improve patient outcomes. Their pipeline includes apitegromab for Spinal Muscular Atrophy (SMA) and SRK-181 for various cancers.
Where is Scholar Rock's Headquarters?
HQ Function
Primary center for research and development, clinical operations, corporate administration, and strategic leadership, driving the company's innovative drug discovery and development programs.
Notable Features:
State-of-the-art laboratory facilities tailored for advanced biologics research and development. Collaborative workspaces designed to foster innovation. Strategically situated within the Kendall Square/Cambridge biotech cluster, providing access to a dense network of talent, research institutions, and industry partners.
Work Culture:
A science-driven, innovative, and collaborative environment focused on tackling challenging diseases with unmet medical needs. Emphasizes teamwork, scientific rigor, urgency, and a patient-centric approach. The culture supports learning and development within a dynamic biotech setting.
HQ Significance:
Located in Cambridge, Massachusetts, a leading global hub for biotechnology and pharmaceutical research. This prime location offers unparalleled access to world-class academic institutions, a rich talent pool of scientists and biotech professionals, and a vibrant ecosystem of venture capital and industry collaborations.
Values Reflected in HQ: The headquarters' focus on cutting-edge research facilities and its location in a premier innovation hub reflect Scholar Rock's commitment to scientific excellence, innovation, and collaboration in its pursuit of developing transformative therapies for patients.
Location:
While headquartered in the United States, Scholar Rock's operational activities, particularly its clinical trials, have a global reach, involving sites and patients in multiple countries across North America, Europe, and potentially other regions. The company collaborates with international research institutions and contract research organizations (CROs) to advance its therapeutic programs. Its mission to address serious diseases with high unmet need is inherently global in perspective, aiming to bring novel therapies to patients worldwide.
Street Address:
620 Memorial Drive, Suite 200W
City:
Cambridge
State/Province:
MA
Country:
USA
Scholar Rock's Global Presence
Buying Intent Signals for Scholar Rock
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Scholar Rock
As of April 2025, Scholar Rock' leadership includes:
Investors of Scholar Rock
Scholar Rock has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Scholar Rock has actively strengthened its executive leadership team over the past 12-18 months with key appointments in medical, commercial, and legal functions to support its growth and pipeline advancement. This includes a new Chief Medical Officer, Chief Commercial Officer, and General Counsel.
Departures
New Appointments:
Technology (Tech Stack) used by Scholar Rock
Discover the tools Scholar Rock uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Scholar Rock Email Formats and Examples
Scholar Rock likely utilizes common corporate email formats, typically combining an employee's name with the 'scholarrock.com' domain. The most probable formats are first initial followed by last name, or first name separated from the last name by a period.
[first_initial][last]@scholarrock.com (e.g., jdoe@scholarrock.com) or [first].[last]@scholarrock.com (e.g., jane.doe@scholarrock.com)
Format
jbackstrom@scholarrock.com
Example
80%
Success rate
News and media
scholarrock.com • March 25, 2024
Scholar Rock Announces Positive Topline Data from SAPPHIRE Phase 3 Trial of Apitegromab in Non-Ambulatory Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA)
Scholar Rock reported positive results from its SAPPHIRE Phase 3 trial, showing that apitegromab led to meaningful improvements in motor function in non-ambulatory patients with Type 2 and 3 SMA. The company plans to engage with regulatory authorities regarding a potential Biologics License Application....more
scholarrock.com • February 27, 2024
Scholar Rock Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
Scholar Rock provided a business update and reported its financial results for the fourth quarter and full year ended December 31, 2023, highlighting progress in its clinical programs and upcoming milestones....more
scholarrock.com • December 11, 2023
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
Scholar Rock announced the appointment of Dr. Jing L. Marantz as its new Chief Medical Officer, bringing significant experience in global clinical development and medical affairs to the company....more
scholarrock.com • November 8, 2023
Scholar Rock to Present Poster on SRK-181 Phase 1 DRUID Trial Data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Scholar Rock announced its participation in the SITC 38th Annual Meeting, where it presented updated data from its Phase 1 DRUID trial evaluating SRK-181, a selective inhibitor of latent TGFβ1 activation, in patients with advanced solid tumors....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Scholar Rock, are just a search away.